[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350799-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350799-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-targetable-dependency-on-nonsense-mediated-decay-for-cellular-homeostasis-and-immune-control-in-small-cell-lung-cancer","A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer","","Small cell lung cancer (SCLC) is highly aggressive yet remains largely refractory to immunotherapy despite abundant genomic alterations that should generate immunogenic neoantigens. The study identifies a hyperactive nonsense-mediated decay (NMD) pathway that counterbalances frameshift mutation immunogenicity by degrading frameshift-mRNA. NMD activity correlates with tumor mutational burden (TMB) across cancers, and in TMBhigh SCLC models NMD inhibition blocks proliferation and triggers ER-stress–dependent apoptosis with misfolded protein accumulation. Genetic and pharmacological NMD inhibition controls TMBhigh tumor growth in vivo. Integrated genome/transcriptome sequencing, MHC-I immunopeptidomics, and functional assays show increased neoantigen expression and presentation, enhancing T cell recognition and improving immunotherapy efficacy, revealing NMD as a tractable TMB-dependent vulnerability.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-targetable-dependency-on-nonsense-mediated-decay-for-cellular-homeostasis-and-immune-control-in-small-cell-lung-cancer/350799/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-targetable-dependency-on-nonsense-mediated-decay-for-cellular-homeostasis-and-immune-control-in-small-cell-lung-cancer/350799.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What mechanism counteracts the immunogenicity of frameshift mutations in SCLC?","Question",{"text":63,"@type":64},"The study shows that a hyperactive nonsense-mediated decay (NMD) pathway degrades frameshift-derived mRNAs, reducing mutation-derived immunogenic material.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does NMD activity relate to tumor mutational burden (TMB)?",{"text":68,"@type":64},"NMD activity correlates with tumor mutational burden (TMB) across cancers, suggesting that SCLC and other TMBhigh tumors may rely on NMD to maintain cellular homeostasis and limit immune recognition.",{"name":70,"@type":61,"acceptedAnswer":71},"What effects does NMD inhibition have on TMBhigh SCLC cells and tumors?",{"text":72,"@type":64},"In TMBhigh models, inhibiting NMD impairs cell proliferation and induces ER-stress–dependent apoptosis. In vivo, both genetic and pharmacological NMD inhibition effectively controls tumor growth with no overt toxicity and boosts neoantigen expression and presentation, increasing T cell recognition and improving immunotherapy efficacy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350799,1790194464,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Torres-Fernández et al. Molecular Cancer (2026) 25:210 Molecular Cancer  \n[https://doi.org/10.1186/s12943-026-02750-2](https://doi.org/10.1186/s12943-026-02750-2)  \nRESEARCH Open Access  \nA targetable dependency on nonsense- mediated decay for cellular homeostasis and immune control in small cell lung cancer  \nLucia A. Torres-Fernández1, Volker Boehm2,3, Joel Kaufmann1, Jonas P. Becker4,5, Maria Garcia-Marquez3,6,  \nBeaunelle de Bruijn1, Agnieszka Rumińska1, Christian Müller1, Graziella Bosco1, Nazanin Alavinejad1, Laura Lovric1, Johanna I. Bihler1, Hanna Schulte1, Poorya Davoodi7,8, Anna Schöllhorn7, Kian R. Weihrauch1, Laura Kaiser1, Olta Ibruli1,9, Fanyu Liu1,10, Ariadne Androulidaki1,10, Nina Wobst1, Marcel Schmiel1,11, JustinasValiulis1, Lukas Maas1, Joshua D’Rozario1, Vignesh Sakthivelu1,12,13, Bianca Göbel1,12,13, Marian Touet9,13, Johannes Brägelmann1,3,12, Katja Höpker14, Felix John15, Jürgen Wolf15, Stefan Knapp16, Alexander Quaas11, Maria Cartolano1, Silvia von Karstedt1,3,10, Filippo Beleggia1,12,13, Hans-Georg Rammensee7,8,17, Cécile Gouttefangeas7,8,17, Hans A. Schlößer3,6, Angelika B. Riemer4,5,18, Hans  \nChristian Reinhardt9, Niels H. Gehring2,3, Martin Peifer1, Roman K. Thomas1,11*† and Julie George1,19*†  \nAbstract  \nSmall cell lung cancer (SCLC) is one of the most aggressive malignancies, characterized by rapid metastatic dissemination and poor overall survival. Despite harboring excessive alterations, expectedly resulting in immunogenic neoantigens, patients with SCLC remain largely refractory to immunotherapy. We found abundant frameshift mutations in SCLC, regarded as highly immunogenic, counterbalanced by a hyperactive nonsensemediated decay (NMD) pathway, responsible for frameshift-mRNA degradation. NMD activity correlated with tumor mutational burden (TMB) across cancers, suggesting that SCLC and other TMBhigh cancers may depend on NMD to limit the accumulation of mutation-derived byproducts in order to maintain cellular homeostasis and evade immune recognition. In TMBhigh SCLC models, inhibition of NMD impaired cell proliferation and induced ER stressdependent apoptosis due to the accumulation of misfolded proteins. Genetic and pharmacological NMD inhibition in vivo effectively controlled TMBhigh tumor growth without overt toxicity. By integrating genome and transcriptome sequencing with MHC-I immunopeptidomics and functional in vitro and in vivo assays, we identified that NMD inhibition boosted neoantigen expression and presentation by tumor cells and increased T cell recognition, thus enhancing overall tumor immunogenicity and further improving immunotherapy efficacy in vivo. Our work shows that SCLC – as a TMBhigh cancer – relies on NMD for survival and immune escape, uncovering a novel TMBdependent tractable vulnerability for this devastating disease.  \n†Roman K. Thomas and Julie George jointly supervised and contributed equally to this work.  \n*Correspondence:  \nRoman K. Thomas [roman.thomas@uni-koeln.de](roman.thomas@uni-koeln.de)[ ](roman.thomas@uni-koeln.de)Julie George [jgeorge@uni-koeln.de](jgeorge@uni-koeln.de)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To v","cbCairVbUKog20tG","https://ap.wps.com/l/cbCairVbUKog20tG","pdf",12595486,37,"English","# Abstract\n# Keywords\n# Background\n## Lung cancer overview\n## SCLC clinical features and immunotherapy limitations\n## Prior SCLC sequencing efforts\n## Unaddressed question","[{\"question\":\"What mechanism counteracts the immunogenicity of frameshift mutations in SCLC?\",\"answer\":\"The study shows that a hyperactive nonsense-mediated decay (NMD) pathway degrades frameshift-derived mRNAs, reducing mutation-derived immunogenic material.\"},{\"question\":\"How does NMD activity relate to tumor mutational burden (TMB)?\",\"answer\":\"NMD activity correlates with tumor mutational burden (TMB) across cancers, suggesting that SCLC and other TMBhigh tumors may rely on NMD to maintain cellular homeostasis and limit immune recognition.\"},{\"question\":\"What effects does NMD inhibition have on TMBhigh SCLC cells and tumors?\",\"answer\":\"In TMBhigh models, inhibiting NMD impairs cell proliferation and induces ER-stress–dependent apoptosis. In vivo, both genetic and pharmacological NMD inhibition effectively controls tumor growth with no overt toxicity and boosts neoantigen expression and presentation, increasing T cell recognition and improving immunotherapy efficacy.\"}]","A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer | PDF",1790091168,93,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c68d5110d8e2ef854fb7cc8a13c69f4d.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/797daf77e4bf19cd92b1e352a92447a1.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/670fe2b7c5e28b3ea826f08eee052f32.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4d5f2c30e9e8704cb6c569dbe387441.webp",980,1306]